GGrantIndex
Sort

48,018 grants matching immunotherapy

DEVELOPMENT OF NANOVAX TM (OIL IN WATER NANOEMULSION ADJUVANT) FORMULATED ALLERGENS AS INTRANASAL IMMUNOTHERAPEUTIC VACCINES FOR PEANUT ALLERGY.

$2,916,500
Ali I. Fattom · Bluewillow Biologics, Inc. · N44 · FY2020 · AI

Antibody Targeted Radiation and Immunotherapy for the Treatment of Solid Tumors

$2,916,216
Andrew A. Raubitschek · Beckman Research Institute/City Of Hope · P01 · FY2008 · CA

Allogeneic Immunotherapy for cancer and nonmalignant hematological disorders

$2,915,077
Richard Childs · National Heart, Lung, And Blood Institute · ZIA · FY2010 · HL

Immunobiology and Immune Therapyfor Merkel Cell Carcinoma

$2,912,785
Paul Nghiem · University Of Washington · P01 · FY2022 · CA

Overcoming mechanisms of therapeutic resistance in pancreatic ductal adenocarcinoma

$2,905,942
Tony R. Hunter · Salk Institute For Biological Studies · P01 · FY2025 · CA

Comprehensive Cancer Center Program at Fox Chase

$2,905,436
Richard I Fisher · Research Inst Of Fox Chase Can Ctr · P30 · FY2019 · CA

Genetic, Cellular and Molecular Mechanisms in Autoimmunity to Retina

$2,904,866
Rachel R. Caspi · National Eye Institute · Z01 · FY2008 · EY

Cancer Center Support Grant

$2,900,000
Dartmouth College · P30 · FY2004 · CA

Immunobiology of Food Allergy and Its Treatment

$2,897,803
Hugh Sampson · Icahn School Of Medicine At Mount Sinai · U19 · FY2015 · AI

Enhancing Chimeric Antigen Receptor T Cell Therapies for Hematologic Malignancies: Beyond CART 19

$2,897,444
Carl H. June · University Of Pennsylvania · P01 · FY2017 · CA

DNA Sequencing and FACS Core Facilities

$2,894,589
Paul Robbins · Division Of Basic Sciences - Nci · ZIC · FY2023 · CA

Moffitt Cancer Center Support Grant

$2,891,925
John L. Cleveland · H. Lee Moffitt Cancer Ctr & Res Inst · P30 · FY2019 · CA

Stanford University Cancer Center

$2,890,663
Beverly Shriver Mitchell · Stanford University · P30 · FY2013 · CA

SPORE in Skin Cancer

$2,885,390
Brigham And Women'S Hospital · P50 · FY2003 · CA

Tissue compartmentalization of human lymphocytes

$2,885,348
Donna L Farber · Columbia University Health Sciences · P01 · FY2019 · AI

Medical Oncology Service Clinical Core

$2,885,087
Arun Rajan · Division Of Basic Sciences - Nci · ZID · FY2024 · CA

Transplant Tolerance in Non-Human Primates

$2,883,601
Christian P Larsen · Emory University · U19 · FY2009 · AI

SPORE IN PROSTATE CANCER

$2,878,971
Johns Hopkins University · P50 · FY2000 · CA

Cancer Immunotherapy Trials Network Central Operations and Statistical Center

$2,878,060
Nancy E Davidson · Fred Hutchinson Cancer Research Center · UM1 · FY2020 · CA

Targeting the Chemokine System to Sensitize Tumors to Immunotherapy

$2,875,855
Pawel Kalinski · Roswell Park Cancer Institute Corp · P01 · FY2023 · CA

(Attack)2: Genetic engineering of cellular and humoral immunity to cure HIV

$2,872,207
Scott G Kitchen · University Of California Los Angeles · U19 · FY2020 · AI

Engineering T cells to Provide Durable Control of HIV-1 Replication

$2,871,467
James L Riley · University Of Pennsylvania · U19 · FY2020 · AI

Vaccine strategies for HIVAIDS

$2,867,414
Jay A Berzofsky · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA

Understanding and Harnessing Microbial Reprogramming to Combat Carcinogenic Colibactin in Colorectal Cancer

$2,864,671
Jiahe Li · University Of Michigan At Ann Arbor · R01 · FY2025 · CA

Enhancing Chimeric Antigen Receptor T Cell Therapies for HematologicMalignancies: Beyond CART 19

$2,863,199
Carl H. June · University Of Pennsylvania · P01 · FY2025 · CA